Alternative splicing in disease and therapy
The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Abstract
Alternative splicing is the major source of proteome diversity in humans and thus is highly relevant to disease and therapy. For example, recent work suggests that the long-sought-after target of the analgesic acetaminophen is a neural-specific, alternatively spliced isoform of cyclooxygenase 1 (COX-1). Several important diseases, such as cystic fibrosis, have been linked with mutations or variations in either cis-acting elements or trans-acting factors that lead to aberrant splicing and abnormal protein production. Correction of erroneous splicing is thus an important goal of molecular therapies. Recent experiments have used modified oligonucleotides to inhibit cryptic exons or to activate exons weakened by mutations, suggesting that these reagents could eventually lead to effective therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the occurrence of elastosis assumes an increase in elastic material in the photoaged skin, as observed in other studies [22, 56].”
From Elastin structure and its involvement in skin photoageing (2017) · cites this paper as [56]
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Human Gene Mutation Database (HGMD®): 2003 update: HGMD 2003 UPDATE
Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S. T., Abeysinghe, S., Krawczak, M., & Cooper, D. N. (2003) · Human Mutation · doi:10.1002/humu.10212 · Cited by 1,829
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
Cited by
Items 101–200 of 529
Thomas, J., Palusa, S. G., Prasad, K. V. S. K., Ali, G. S., Surabhi, G., Ben‐Hur, A., Abdel‐Ghany, S. E., & Reddy, A. S. N. (2012) · The Plant Journal · doi:10.1111/tpj.12004 · Cited by 77
Izquierdo, J. M., & Valcárcel, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700688200 · Cited by 84
HOLLYWOOD: a comparative relational database of alternative splicing
Holste, D., Huo, G., Tung, V., & Burge, C. B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj048 · Cited by 84
A microarray configuration to quantify expression levels and relative abundance of splice variants
Fehlbaum, P. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni047 · Cited by 74
Hims, M. M., Ibrahim, E. C., Leyne, M., Mull, J., Liu, L., Lázaro, C., Shetty, R. S., Gill, S., Gusella, J. F., Reed, R., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0137-2 · Cited by 69
c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway
Rauch, J., Moran‐Jones, K., Albrecht, V. S., Schwarzl, T., Hunter, K. D., Gires, O., & Kölch, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4447 · Cited by 77
DDIG-in: discriminating between disease-associated and neutral non-frameshifting micro-indels
Zhao, H., Yang, Y., Lin, H., Zhang, X., Mort, M. E., Cooper, D. N., Liu, Y., & Zhou, Y. (2013) · Genome biology · doi:10.1186/gb-2013-14-3-r23 · Cited by 74
Ghigna, C., de Toledo, M., Bonomi, S., Valacca, C., Gallo, S., Apicella, M., Eperon, I. C., Tazi, J., & Biamonti, G. (2010) · RNA Biology · doi:10.4161/rna.7.4.12744 · Cited by 70
The determinants of alternative RNA splicing in human cells
Ramanouskaya, T. V., & Grinev, V. V. (2017) · Molecular Genetics and Genomics · doi:10.1007/s00438-017-1350-0 · Cited by 79
Functional coupling of transcription and splicing
Montes, M., Becerra, S., Sánchez‐Álvarez, M., & Suñé, C. (2012) · Gene · doi:10.1016/j.gene.2012.04.006 · Cited by 90
Salovska, B., Zhu, H., Gandhi, T., Frank, M., Li, W., Rosenberger, G., Wu, C., Germain, P., Zhou, H., Hodny, Z., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199170 · Cited by 71
The spliceosome: a novel multi-faceted target for therapy
Tazi, J., Durand, S., & Jeanteur, P. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.06.002 · Cited by 71
Potashkin, J. A., & Meredith, G. E. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.144 · Cited by 64
Rodríguez-Martín, T., García-Blanco, M. A., Mansfield, S. G., Grover, A., Hutton, M. L., Yu, Q., Zhou, J., Anderton, B. H., & Gallo, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503150102 · Cited by 69
Investigation of somatic NKX2-5 mutations in congenital heart disease
Draus, J. M., Hauck, M. A., Goetsch, M. A., Austin, E. H., Tomita‐Mitchell, A., & Mitchell, M. E. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060277 · Cited by 62
Menon, R., & Omenn, G. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2631 · Cited by 61
DeLong, R. K., Risor, A., Kanomata, M., Laymon, A., Jones, B., Zimmerman, S., Williams, J. F., Witkowski, C. M., Warner, M., Ruff, M., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.70 · Cited by 61
Tumor‐specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma
Cengiz, B., Gündüz, E., Gündüz, M., BEDER, L. B., Tamamura, R., Bağcı, C., Yamanaka, N., Shimizu, K., & Nagatsuka, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25224 · Cited by 60
Analyzing Microarray Data of Alzheimer's Using Cluster Analysis to Identify the Biomarker Genes
Guttula, S. V., Apparao, A., & Gumpeny, R. S. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/649456 · Cited by 68
Alternatively and Constitutively Spliced Exons Are Subject to Different Evolutionary Forces
Chen, F., Wang, S., Chen, C.-J., Li, W., & Chuang, T. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msj081 · Cited by 67
Entropy Measures Quantify Global Splicing Disorders in Cancer
Ritchie, W., Granjeaud, S., Puthier, D., & Gautheret, D. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000011 · Cited by 75
Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders
Glatt, S. J., Cohen, O. S., Faraone, S. V., & Tsuang, M. T. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31181 · Cited by 63
Studying alternative splicing regulatory networks through partial correlation analysis
Chen, L., & Zheng, S. (2009) · Genome Biology · doi:10.1186/gb-2009-10-1-r3 · Cited by 59
Spliceosome-Mediated RNA Trans-splicing
Yang, Y., & Walsh, C. E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.006 · Cited by 59
Comprehensive assessment of mRNA isoform detection methods for long-read sequencing data
Su, Y., Yu, Z., Jin, S., Ai, Z., Yuan, R., Chen, X., Xue, Z., Guo, Y., Chen, D., Liang, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48117-3 · Cited by 68
Abes, R., Arzumanov, A. A., Moulton, H. M., Abes, S., Ivanova, G. D., Gait, M. J., Iversen, P. L., & Lebleu, B. (2008) · Journal of Peptide Science · doi:10.1002/psc.979 · Cited by 59
NickFects, Phosphorylated Derivatives of Transportan 10 for Cellular Delivery of Oligonucleotides
Oskolkov, N., Arukuusk, P., Copolovici, D. M., Lindberg, S., Margus, H., Padari, K., Pooga, M., & Langel, Ü. (2011) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-011-9252-1 · Cited by 59
Montes, M., Cloutier, A., Sánchez-Hernández, N., Michelle, L., Lemieux, B., Blanchette, M., Hernández-Munaín, C., Chabot, B., & Suñé, C. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06255-11 · Cited by 76
SRSF3: Newly discovered functions and roles in human health and diseases
More, D. A., & Kumar, A. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151099 · Cited by 65
Zhang, L., Vlad, A., Milcarek, C., & Finn, O. J. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1325-2 · Cited by 62
The roles played by highly truncated splice variants of G protein-coupled receptors
Wise, H. M. (2012) · Journal of Molecular Signaling · doi:10.1186/1750-2187-7-13 · Cited by 60
Rodríguez-Martín, T., Anthony, K., García-Blanco, M. A., Mansfield, S. G., Anderton, B. H., & Gallo, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp264 · Cited by 62
Emerging Methods and Resources for Biological Interrogation of Neuropsychiatric Polygenic Signal
Uffelmann, E., & Posthuma, D. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.022 · Cited by 56
Zhang, X., Yin, Y. S., Wang, J., Battaglia, T., Krautkramer, K. A., Li, W. V., Li, J., Brown, M., Zhang, M., Badri, M. H., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.014 · Cited by 58
Coutinho-Mansfield, G. C., Xue, Y., Zhang, Y., & Fu, X.-D. (2007) · Genes & Development · doi:10.1101/gad.1575607 · Cited by 56
Nagao, K., Togawa, N., Fujii, K., Uchikawa, H., Kohno, Y., Yamada, M., & Miyashita, T. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi369 · Cited by 62
Zheng, S., & Chen, L. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp282 · Cited by 55
Wang, X. G., Ju, Z., Hou, M. H., Jiang, Q., Yang, C. H., Zhang, Y., Sun, Y., Li, R. L., Wang, C. F., Zhong, J. F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159719 · Cited by 75
Hiller, M., Huse, K., Szafranski, K., Jahn, N., Hampe, J., Schreiber, S., Backofen, R., & Platzer, M. (2006) · The American Journal of Human Genetics · doi:10.1086/500151 · Cited by 54
Kandpal, R. P., Rajasimha, H. K., Brooks, M. J., Nellissery, J. K., Wan, J., Qian, J. X., Kern, T. S., & Swaroop, A. (2012) · PubMed Central · Cited by 57
Oren, Y. S., Sinai, M. I., Golec, A., Barchad-Avitzur, O., Mutyam, V., Yao, L., Hong, J. S., Ozeri-Galai, E., Hatton, A., Leibson, C., et al. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.06.003 · Cited by 61
Vickers, T. A., Zhang, H., Graham, M. J., Lemonidis, K. M., Zhao, C., & Dean, N. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3652 · Cited by 54
Moors, M., Vudattu, N. K., Abel, J., Krämer, U., Rane, L., Ulfig, N., Ceccatelli, S., Seyfert-Margolies, V., Fritsche, E., & Maeurer, M. J. (2009) · Genes and Immunity · doi:10.1038/gene.2009.77 · Cited by 60
Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development
Peterson, M. L. (2007) · Immunologic Research · doi:10.1007/bf02686094 · Cited by 55
Alternative Transcript Initiation and Splicing as a Response to DNA Damage
Sprung, C. N., Li, J., Hovan, D., McKay, M. J., & Forrester, H. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025758 · Cited by 58
Vaccination against self to prevent autoimmune disease: the type 1 diabetes model
Harrison, L. C. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100151 · Cited by 52
Evolution of alternative splicing in primate brain transcriptomes
Lin, L., Shen, S., Jiang, P., Sato, S., Davidson, B. L., & Xing, Y. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq201 · Cited by 52
Extraction of Transcript Diversity from Scientific Literature
Shah, P. K., Jensen, L. J., Boué, S., & Bork, P. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010010 · Cited by 52
Characterization and performance of nucleic acid nanoparticles combined with protamine and gold
DeLong, R. K., Akhtar, U. S., Sallee, M., Parker, B., Barber, S., Zhang, J., Craig, M., Garrad, R. C., Hickey, A. J., & Engstrom, E. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.067 · Cited by 53
Takeuchi, Y., Mishima, E., Shima, H., Akiyama, Y., Suzuki, C., Suzuki, T., Kobayashi, T., Suzuki, Y., Nakayama, T., Takeshima, Y., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013091013 · Cited by 51
Coombs, T. C., Tanega, C., Shen, M., Wang, J. L., Auld, D. S., Gerritz, S. W., Schoenen, F. J., Thomas, C. J., & Aubé, J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.096 · Cited by 58
Data Analysis Pipeline for RNA‐seq Experiments: From Differential Expression to Cryptic Splicing
Yalamanchili, H. K., Wan, Y., & Liu, Z. (2017) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.33 · Cited by 59
Chemical Modifications to Improve the Cellular Uptake of Oligonucleotides
Debart, F., Abes, S., Deglane, G., Moulton, H. M., Clair, P., Gait, M. J., Vasseur, J., & Lebleu, B. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780487704 · Cited by 52
Laufer, S., & Restle, T. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786898806 · Cited by 59
Targeting Splicing in the Treatment of Human Disease
Suñé-Pou, M., Prieto‐Sánchez, S., Boyero-Corral, S., Moreno‐Castro, C., Yousfi, Y. E., Suñé-Negre, J. M., Hernández-Munaín, C., & Suñé, C. (2017) · Genes · doi:10.3390/genes8030087 · Cited by 54
Functional significance of U2AF1 S34F mutations in lung adenocarcinomas
Esfahani, M. S., Lee, L. J., Jeon, Y.-J., Flynn, R. A., Stehr, H., Hui, A. B., Ishisoko, N., Kildebeck, E., Newman, A. M., Bratman, S. V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13392-y · Cited by 56
Tang, T. J., Han, Y., Wang, Y., Huang, H., & Qian, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.677587 · Cited by 55
Detection of human interchromosomal trans-splicing in sequence databanks
Herai, R. H., & Yamagishi, M. E. B. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp041 · Cited by 49
A mechanism for low penetrance in an ALS family with a novel SOD1 deletion
Zinman, L. H., Liu, H. N., Sato, C., Wakutani, Y., Marvelle, A. F., Moreno, D., Morrison, K. E., Mohlke, K. L., Bilbao, J. M., Robertson, J., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000345363.65799.35 · Cited by 49
ASPicDB: A database resource for alternative splicing analysis
Castrignanò, T., D’Antonio, M., Anselmo, A., Carrabino, D., Meo, A. D. D., D’Erchia, A. M., Licciulli, F., Mangiulli, M., Mignone, F., Pavesi, G., et al. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn113 · Cited by 50
Alternative splicing of the neurofibromatosis type I pre-mRNA
Barron, V. A., & Lou, H. J. (2011) · Bioscience Reports · doi:10.1042/bsr20110060 · Cited by 63
Evsyukova, I. Y., Bradrick, S. S., Gregory, S. G., & García-Blanco, M. A. (2012) · RNA · doi:10.1261/rna.035410.112 · Cited by 55
RNA regulation and cancer development
Scholzová, E., Malík, R., Ševčík, J., & Kleibl, Z. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.03.021 · Cited by 57
Variable window binding for mutually exclusive alternative splicing
Anastassiou, D., Liu, H., & Varadan, V. (2006) · Genome biology · doi:10.1186/gb-2006-7-1-r2 · Cited by 47
Weak definition ofIKBKAPexon 20 leads to aberrant splicing in familial dysautonomia
Ibrahim, E. C., Hims, M. M., Shomron, N., Burge, C. B., Slaugenhaupt, S. A., & Reed, R. (2006) · Human Mutation · doi:10.1002/humu.20401 · Cited by 46
Cibi, D. M., Mia, M. M., Shekeran, S. G., Yun, L. S., Sandireddy, R., Gupta, P. S., Hota, M., Sun, L., Ghosh, S., & Singh, M. K. (2019) · eLife · doi:10.7554/elife.45418 · Cited by 50
Pre-mRNA splicing aberrations and cancer
Christopher, A. P. (2007) · Frontiers in bioscience · doi:10.2741/2747 · Cited by 54
Tazi, J., Bakkour, N., Soret, J., Zekri, L., Hazra, B., Laine, W., Baldeyrou, B., Lansiaux, A., & Bailly, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007633 · Cited by 44
Pre-mRNA Missplicing as a Cause of Human Disease
Novoyatleva, T., Tang, Y., Rafalska, I., & Stamm, S. (2006) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-34449-0_2 · Cited by 55
Characterization of the Intronic Splicing Silencers Flanking FGFR2 Exon IIIb
Wagner, E. J., Baraniak, A. P., Sessions, O. M., Mauger, D., Moskowitz, E. J., & García-Blanco, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414492200 · Cited by 44
Self-citationLi, S.-Q., Liu, J., Zhang, J., Wang, X., Chen, D., Wang, Y., Xu, Y., Huang, B., Jin, L., Li, J., et al. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.04.016 · Cited by 47
Alternative splicing interference by xenobiotics
Zaharieva, E. E., Chipman, J. K., & Soller, M. (2012) · Toxicology · doi:10.1016/j.tox.2012.01.014 · Cited by 58
Novel roles of U1 snRNP in alternative splicing regulation
Buratti, E., & Baralle, D. (2010) · RNA Biology · doi:10.4161/rna.7.4.12153 · Cited by 53
The nonessentiality of essential genes in yeast provides therapeutic insights into a human diseasePreprint
Chen, P., Wang, D., Chen, H., Zhou, Z., & He, X. (2016) · Genome Research · doi:10.1101/gr.205955.116 · Cited by 46
The role of CELF proteins in neurological disorders
Gallo, J., & Spickett, C. (2010) · RNA Biology · doi:10.4161/rna.7.4.12345 · Cited by 46
Splicing dysregulation as a driver of breast cancer
Read, A., & Natrajan, R. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0068 · Cited by 43
Ryan, M. C., Zeeberg, B. R., Caplen, N. J., Cleland, J. A., Kahn, A. B., Liu, H., & Weinstein, J. N. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-313 · Cited by 41
Alternative splicing in aging and age-related diseases
Li, H., Wang, Z., Ma, T., Wei, G., & Ni, T. (2017) · Translational Medicine of Aging · doi:10.1016/j.tma.2017.09.005 · Cited by 45
Netrin Family: Role for Protein Isoforms in Cancer
Bruikman, C. S., Zhang, H., Kemper, A. M., & van Gils, J. M. (2019) · Journal of Nucleic Acids · doi:10.1155/2019/3947123 · Cited by 44
PNA-based artificial nucleases as antisense and anti-miRNA oligonucleotide agents
Gaglione, M., Milano, G., Chambery, A., Moggio, L., Romanelli, A., & Messere, A. (2011) · Molecular BioSystems · doi:10.1039/c1mb05131h · Cited by 40
Dynamic usage of alternative splicing exons during mouse retina development
Wan, J., Masuda, T., Hackler, L., Torres, K. M., Merbs, S. L., Zack, D. J., & Qian, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr545 · Cited by 38
Sirsi, S. R., Schray, R. C., Guan, X., Lykens, N. M., Williams, J. H., Erney, M. L., & Lutz, G. J. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.129 · Cited by 39
Redirecting splicing with bifunctional oligonucleotides
Brosseau, J., Lucier, J., Lamarche, A.-A., Shkreta, L., Gendron, D., Lapointe, E., Thibault, P., Paquet, É. R., Perreault, J., Elela, S. A., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1287 · Cited by 50
Bioinformatics of alternative splicing and its regulation
Florea, L. (2006) · Briefings in Bioinformatics · doi:10.1093/bib/bbk005 · Cited by 41
Huh, J., Kim, Y., Park, S.-J., Kim, D., Lee, S., Kim, K.-M., Jeong, K.-J., Kim, J.-S., Song, B., Sim, B., et al. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-163 · Cited by 38
Nariai, N., Hirose, O., Kojima, K., & Nagasaki, M. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt381 · Cited by 37
Zhang, Y., Wang, X., Jiang, Q., Hao, H., Ju, Z., Yang, C., Sun, Y., Wang, C., Zhong, J., Huang, J., et al. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0871-0 · Cited by 38
Tan, S., Wang, W., Tian, C., Niu, D., Zhou, T., Yang, Y., Gao, D., & Liu, Z. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.05.008 · Cited by 38
Oltean, S., Febbo, P. G., & García-Blanco, M. A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9186-y · Cited by 39
The Pivotal Roles of TIA Proteins in 5′ Splice-Site Selection of Alu Exons and Across Evolution
Gal-Mark, N., Schwartz, S., Ram, O., Eyras, E., & Ast, G. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000717 · Cited by 39
Tailoring of Membrane Proteins by Alternative Splicing of Pre-mRNA
Mittendorf, K. F., Deatherage, C. L., Ohi, M. D., & Sanders, C. R. (2012) · Biochemistry · doi:10.1021/bi3007065 · Cited by 44
Specific correction of a splice defect in brain by nutritional supplementation
Shetty, R. S., Gallagher, C. S., Chen, Y., Hims, M. M., Mull, J., Leyne, M., Pickel, J. M., Kwok, D., & Slaugenhaupt, S. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr333 · Cited by 36
TassDB: a database of alternative tandem splice sites
Hiller, M., Nikolajewa, S., Huse, K., Szafranski, K., Rosenstiel, P. C., Schuster, S., Backofen, R., & Platzer, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl762 · Cited by 40
McCullough, R. M., Cantor, C. R., & 丁春明 (2005) · Nucleic Acids Research · doi:10.1093/nar/gni098 · Cited by 36
Muscle-Specific Mis-Splicing and Heart Disease Exemplified by RBM20
Rexiati, M., Sun, M., & Guo, W. (2018) · Genes · doi:10.3390/genes9010018 · Cited by 37
Laurent, G. S., Savva, Y. A., & Kapranov, P. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00057 · Cited by 38
Spliceosomes walk the line: Splicing errors and their impact on cellular function
Hsu, S.-N., & Hertel, K. J. (2009) · RNA Biology · doi:10.4161/rna.6.5.9860 · Cited by 38
A saga of cancer epigenetics: linking epigenetics to alternative splicing
Narayanan, S. P., Singh, S., & Shukla, S. (2017) · Biochemical Journal · doi:10.1042/bcj20161047 · Cited by 42
Wang, H., Wang, H., Duan, X., Sun, Y., Wang, X., & Li, Z. (2017) · Chemical Science · doi:10.1039/c7sc00094d · Cited by 34
RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies
Gallo, J., Noble, W. J., & Martin, T. R. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6513-4 · Cited by 39
Metadata
- Authors
- Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L.
- Affiliations
- Duke University (US)
- ORCID
- Lasda, Erika L
- Venue
- Nature Biotechnology
- Published
- 2004-05
- Volume
- 22
- Issue
- 5
- Pages
- 535-546
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2070564797
- Cited by
- 527
- References
- 192
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 16 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 15 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 21 · 2014: 20 · 2013: 28 · 2012: 33
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R33CA097502, R33 CA97502)
- National Institute of General Medical Sciences (R01GM063090, R01 GM 63090)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- alternative splicing, proteome diversity, cystic fibrosis, aberrant splicing, cis-regulatory elements, trans-acting splicing factors, cyclooxygenase-1, paracetamol, cryptic exons, modified oligonucleotides, splicing correction, molecular therapy
- MeSH terms
- Base Sequence, Humans, Phenotype, RNA, Therapeutics, Alternative Splicing, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.